SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-057311
Filing Date
2009-11-04
Accepted
2009-11-04 09:31:21
Documents
10
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 CORNERSTONE THERAPEUTICS INC. b77488e10vq.htm 10-Q 439326
2 EX-10.2 LICENSE AND OPTION AGREEMENT BETWEEN LG LIFE SCIENCES, LTD. AND CORNERST b77488exv10w2.htm EX-10.2 657730
3 EX-10.3 LEASE MODIFICATION AGREEMENT NO. 1, DATED OCTOBER 31, 2008 b77488exv10w3.htm EX-10.3 26042
4 EX-10.4 LEASE MODIFICATION AGREEMENT NO. 2, DATED OCTOBER 2, 2009 b77488exv10w4.htm EX-10.4 65881
5 EX-10.5 SECOND AMENDMENT, DATED JULY 27, 2009, TO AMENDED AND RESTATED RESTRICTE b77488exv10w5.htm EX-10.5 17057
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b77488exv31w1.htm EX-31.1 8169
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b77488exv31w2.htm EX-31.2 8187
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO b77488exv32w1.htm EX-32.1 4230
9 EX-32.2 SECTION 906 CERTIFICATION OF CFO b77488exv32w2.htm EX-32.2 4262
10 GRAPHIC b77488b7748801.gif GRAPHIC 4250
  Complete submission text file 0000950123-09-057311.txt   1238435
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 091156421
SIC: 2834 Pharmaceutical Preparations